ArticlePhysics and imaging in radiation oncology2026
Segmentation regularized training for multi-domain deep learning registration applied to magnetic resonance-guided prostate cancer radiotherapy.
Article in Physics and imaging in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Background and purpose: Accurate deformable image registration (DIR) is required for contour propagation and dose accumulation for magnetic resonance guided adaptive radiotherapy (MRgART). The goal of this study was to train segmentation regularized deep learning (DL) DIR and assess domain invariant MR-MR registration. Materials and methods: DL-DIR based progressively refined registration and segmentation (ProRSeg) and VoxelMorph were trained with and without organ weighted segmentation regularization with 262 MR pairs from same domain dataset of longitudinal 3 Tesla MR simulation (MR-Sim) scans of patients with prostate cancer acquired before and every 3 months following radiotherapy. Models were compared against variational DIR by measuring accuracy of organs and clinical target volume (CTV) contour propagation accuracy on same- (58 pairs), cross- (72 1.5 Tesla MR-Linac pairs from consecutive daily treatment fractions), and mixed-domain (42 MRSim planning - MR-Linac first fraction pairs) datasets. Dose accumulation was performed for 42 patients undergoing 5-fraction MRgART on MR-Linac. Results: ProRSeg produced robust DIR on cross- (all organs) and mixed-domain (bladder, CTV) datasets. It was the most accurate method for highly deforming organs including bladder and rectum. Segmentation regularization enhanced accuracy of both ProRSeg and VoxelMorph compared to unregularized versions. Dose accumulation feasibility study with ProRSeg indicated that 83.3% of patients met key institutional constraints for CTV coverage and bladder sparing. Conclusions: ProRSeg was a feasible approach for multi-domain MR-MR registration for prostate cancer patients. Dose accumulation analysis indicated preliminary feasibility to evaluate compliance of delivered treatments to clinical constraints.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.